Part of treatment Medical weight loss
Weight loss medication
The medications listed below are part of the Medical Weight Loss treatment and are offered only as part of this treatment. All medication is prescription. If you are eligible for treatment, the medication will be prescribed by our doctor and dispensed by our affiliated pharmacist.
Saxenda
Saxenda (substance name Liraglutide) is an injectable drug used to help obese adults lose and maintain weight. Developed by the pharmaceutical company Novo Nordisk, Saxenda is available by prescription only. Read more about Saxenda…
| Administration: | Daily lancing pen |
| Active ingredient: | Liraglutide |
| Target audience: | Obesity: BMI≥30, or BMI≥27 with a weight-related condition |
| Explanation of operation: | The drug is similar to the natural GLP-1 hormone. It regulates appetite and increases feelings of satiety |
| Side effects: | The most common side effects are nausea, vomiting, diarrhea, constipation, headache and fatigue. |
| Package insert: | Download the Saxenda package insert. |
| Price: | The medication is not available separately, but only as part of the treatment medical weight loss. Indpendent program
Care program
|
Ozempic
Ozempic (semaglutide) is an injectable prescription medication used to treat type 2 diabetes. It belongs to a class of drugs called glucagon-like peptide-1 (GLP-1) receptor agonists, which act on the body’s natural GLP-1 receptors to help regulate blood sugar levels. Read more about Ozempic…
| Administration: | Weekly lancing pen |
| Active ingredient: | Semaglutide |
| Target audience: | Diabetes mellitus type 2 |
| Explanation of operation: | The drug is similar to the natural GLP-1 hormone. It regulates appetite and increases feelings of satiety |
| Side effects: | The most common side effects are headache, nausea, diarrhea, constipation, vomiting and fatigue. |
| Package insert: | Download the Ozempic package insert. |
| Price: | The medication is not available separately, but only as part of the treatment medical weight loss. Indpendent program
Care program
|
Wegovy
Wegovy contains the active ingredient Semaglutide, an analog of glucagon-like peptide 1 (GLP-1), which helps regulate food intake and energy expenditure to promote weight loss. Wegovy can be used as adjunctive therapy for obese or overweight adult patients who have at least one health condition related to their obesity, such as type 2 diabetes, high blood pressure or dyslipidemia (high cholesterol). Read more about Wegovy…
| Administration: | Weekly lancing pen |
| Active ingredient: | Semaglutide |
| Target audience: | Obesity: BMI≥30, or BMI≥27 with a weight-related condition |
| Explanation of operation: | The drug is similar to the natural GLP-1 hormone. It regulates appetite and increases feelings of satiety |
| Side effects: | The most common side effects are headache, nausea, diarrhea, constipation, vomiting and fatigue. |
| Package insert: | Download Wegovy’s package insert. |
| Price: | The medication is not available separately, but only as part of the treatment medical weight loss. Indpendent program
Care program
|
Mounjaro
Mounjaro is a brand name for a drug known as Tirzepatide. It is used to treat type 2 diabetes and for weight management. Mounjaro works by lowering blood sugar levels and improving insulin production in the body. This drug also has beneficial effects on weight loss, making it a popular choice for obese or overweight individuals. Read more about Mounjaro…
| Administration: | Weekly lancing pen |
| Active ingredient: | Tirzepatide |
| Target audience: | Diabetes mellitus type 2 & Obesity: BMI≥30, or BMI≥27 with a weight-related condition |
| Explanation of operation: | The drug is similar to the natural GLP-1 hormone. It regulates appetite and increases feelings of satiety |
| Side effects: | The most common side effects are hypoglycemia, headache, nausea, diarrhea, constipation, vomiting and fatigue. |
| Package insert: | Download the package insert for Mounjaro. |
| Price: | The medication is not available separately, but only as part of the treatment medical weight loss. Indpendent program
Care program
|
Rybelsus
Rybelsus is a drug used to treat type 2 diabetes. Rybelsus works by stimulating insulin production and reducing the amount of glucose produced by the liver. This helps keep blood sugar levels within a healthy range and can reduce risk factors for diabetes such as heart disease, stroke and kidney damage. Read more about Rybelsus…
| Administration: | Pill form, 3x daily |
| Active ingredient: | Semaglutide |
| Target audience: | Diabetes mellitus type 2 |
| Explanation of operation: | The drug is similar to the natural GLP-1 hormone. It regulates appetite and increases feelings of satiety |
| Side effects: | The most common side effects are hypoglycemia, headache, nausea, diarrhea, constipation, vomiting and fatigue. |
| Package insert: | Download the package insert for Rybelsus. |
| Price: | The medication is not available separately, but only as part of the treatment medical weight loss. Indpendent program
Care program
|
Mysimba
Mysimba (substance names: naltrexone and bupropion) is an oral medication used to help obese adults lose and maintain weight. This drug acts on areas of the brain involved in the regulation of food intake and energy consumption. Read more about Mysimba…
| Administration: | Pill form, 2x daily |
| Active ingredient: | Naltrexone / Bupropion |
| Target audience: | Obesity |
| Explanation of operation: | The drug acts on the craving system in the body and prevents impulse eating. |
| Side effects: | The most common side effects are dizziness, headache, palpitations, fatigue, insomnia. |
| Package insert: | Download the package insert for Mysimba. |
| Price: | The medication is not available separately, but only as part of the treatment medical weight loss. Indpendent program
Care program
|
